文献速递疼痛医学神经外科与老年麻醉

槲皮素通过阻断电压门控钠通道缓解慢性口面部疼痛

Quercetin, Main Active Ingredient of Moutan Cortex, Alleviates Chronic Orofacial Pain via Block of Voltage-Gated Sodium Channel.
PubMed 文献 · Anesth Analg · 2024-05-20

本研究通过网络药理学和动物实验探讨牡丹皮主要活性成分槲皮素治疗慢性口面部疼痛的机制。在LPS诱导的大鼠模型中,槲皮素显著提高机械痛阈,并可能通过阻断三叉神经节神经元电压门控钠通道、下调促炎因子FOS和TNF-α表达发挥镇痛作用。

要点

  • 槲皮素可缓解LPS诱导的大鼠慢性口面部疼痛机械性异常性疼痛。
  • 槲皮素镇痛机制可能与阻断三叉神经节神经元Nav通道有关。
  • 槲皮素还下调促炎因子FOS和TNF-α的mRNA表达。

核心结论

  • 槲皮素是牡丹皮治疗慢性口面部疼痛的主要活性成分,其镇痛机制与阻断电压门控钠通道及下调促炎因子有关。

研究设计与样本

  • 研究采用网络药理学和生物信息学分析筛选牡丹皮活性成分及靶点,并建立LPS诱导的成年雄性Sprague-Dawley大鼠慢性口面部疼痛模型进行体内外实验验证。

临床怎么用

  • 槲皮素可能作为慢性口面部疼痛的潜在治疗选择,其机制涉及钠通道阻断和抗炎作用。

局限性

  • 研究仅在大鼠模型和体外细胞中进行,尚未在人体中验证槲皮素的疗效和安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic orofacial pain (COP) therapy is challenging, as current medical treatments are extremely lacking. Moutan Cortex (MC) is a traditional Chinese medicine herb widely used for chronic inflammatory diseases. However, the mechanism behind MC in COP therapy has not been well-established. The purpose of this study was to identify the active ingredients of MC and their specific underlying mechanisms in COP treatment. METHODS: In this study, the main active ingredients and compound-target network of MC in COP therapy were identified through network pharmacology and bioinformatics analysis. Adult male Sprague-Dawley rats received oral mucosa lipopolysaccharide (LPS) injection to induce COP. Pain behaviors were evaluated by orofacial mechanical nociceptive assessment after intraganglionar injection. In vitro inflammatory cytokines in LPS-pretreated human periodontal ligament stem cells (hPDLSCs) and rat primary cultural trigeminal ganglion (TG) neurons were quantified by real-time quantitative polymerase chain reaction (RT-qPCR). Schrödinger software was used to verify the molecular docking of quercetin and critical targets. Whole-cell recording electrophysiology was used to evaluate the effect of quercetin on voltage-gated sodium (Na v ) channel in rat TG neurons. RESULTS: The assembled compound-target network consisted of 4 compounds and 46 targets. As 1 of the active components of MC correlated with most related targets, quercetin alleviated mechanical allodynia in LPS-induced rat model of COP (mechanical allodynia threshold median [interquartile range (IQR) 0.5 hours after drug administration: vehicle 1.3 [0.6-2.0] g vs quercetin 7.0 [6.0-8.5] g, P = .002). Gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis revealed that immune response and membrane functions play essential roles in MC-COP therapy. Five of the related targets were identified as core targets by protein-protein interaction analysis. Quercetin exerted an analgesic effect, possibly through blocking Na v channel in TG sensory neurons (peak current density median [IQR]: LPS -850.2 [-983.6 to -660.7] mV vs LPS + quercetin -589.6 [-711.0 to -147.8] mV, P = .006) while downregulating the expression level of proinflammatory cytokines-FOS (normalized messenger RNA [mRNA] level mean ± standard error of mean [SEM]: LPS [2. 22 ± 0.33] vs LPS + quercetin [1. 33 ± 0.14], P = .034) and TNF-α (normalized mRNA level mean ± SEM: LPS [8. 93 ± 0.78] vs LPS + quercetin [3. 77 ± 0.49], P < .0001). CONCLUSIONS: Identifying Na v as the molecular target of quercetin clarifies the analgesic mechanism of MC, and provides ideas for the development of novel selective and efficient chronic pain relievers.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Liu Z, Shan Z, Yang H, et al. Quercetin, Main Active Ingredient of Moutan Cortex, Alleviates Chronic Orofacial Pain via Block of Voltage-Gated Sodium Channel. Anesth Analg. 2024. PMID: 37968831. doi:10.1213/ANE.0000000000006730

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。